Back to today’s briefing

Story perspectives

Federal Agencies Scrub DEI Pages, Risking Health Disparities

2/4/2025

39 3

Summary

Story summary

Federal agencies have taken down web pages focused on diversity, equity, and inclusion (DEI) in clinical trials, sparking worries about worsening health disparities. Experts emphasize that diverse representation is crucial for reliable treatment outcomes and fair healthcare access. The FDA and National Cancer Institute are among those impacted by this significant shift.

1 of 1

Story summary

Federal agencies have taken down web pages focused on diversity, equity, and inclusion (DEI) in clinical trials, sparking worries about worsening health disparities. Experts emphasize that diverse representation is crucial for reliable treatment outcomes and fair healthcare access. The FDA and National Cancer Institute are among those impacted by this significant shift.